Check out the new and improved FierceBiomarkers website

Arsalan Arif, Publisher
Follow me on Twitter and LinkedIn

Dear readers: We've completed a major overhaul of FierceBiomarkers' website.

We had one guiding principle with the redesign. It's best captured by Jay Rosen, a prominent press critic and journalism professor at NYU:

"The simplest way to create value in journalism is to save the user time."

Please explore the streamlined new design and let us know if we indeed are saving you time. You, our readers, are some of the busiest executives in the world, so our mission is to give you great content and context in the daily biopharma news picture as expeditiously as possible. Drop me a line, tell us how we're doing in that regard. After all, we built it for you.

 

Suggested Articles

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s sequel to its VC megafund.

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.